Therapy-related Myelodysplastic Syndrome
📧 Sign up to get email alerts when something new happens for Therapy-related Myelodysplastic Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: Venetoclax and Azacitidine for Treatment of Therapy Related or Secondary Myelodysplastic Syndrome [Phase 2]
Phase 2 clinical trial evaluating venetoclax combined with azacitidine for therapy-related or secondary myelodysplastic syndrome; the study …
-
CLINICAL_TRIALS trial_result · 2025-09-26Clinical Trial Update: Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies [Phase 3]
A Phase 3 randomized trial evaluating Orca-T in allogeneic stem cell transplantation for hematologic malignancies; results have been posted.
-
CLINICAL_TRIALS trial_result · 2023-11-07Clinical Trial Update: Donor Natural Killer Cells and Donor Stem Cell Transplant in Treating Patients With High Risk Myeloid Malignancies [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating donor natural killer cells and donor stem cell transplant in high-risk myeloid malignancies; completed w…
-
CLINICAL_TRIALS trial_result · 2023-04-04Clinical Trial Update: Clofarabine and Melphalan Before Donor Stem Cell Transplant in Treating Patients With Myelodysplasia, Acute Leukemia in Remission, or Chronic Myelomonocytic Leukemia [Phase 2]
Phase 2 trial evaluating Clofarabine plus Melphalan as a conditioning regimen before donor stem cell transplantation for patients with myelo…
-
CLINICAL_TRIALS trial_result · 2020-06-09Clinical Trial Update: Vosaroxin and Infusional Cytarabine in Treating Patients With Untreated Acute Myeloid Leukemia [Phase 2]
Phase 2 clinical trial update evaluating vosaroxin with infusional cytarabine for untreated acute myeloid leukemia; results have been posted…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.